Literature DB >> 8757927

Enzyme linked immunosorbent assay for detecting benzodiazepines in urine.

D Laurie1, A J Mason, N H Piggott, F J Rowell, J Seviour, D Strachan, J D Tyson.   

Abstract

A relatively simple ELISA technique was developed for the detection of a range of benzodiazepines (BZs) in urine. The assay employs a mouse anti-oxazepam antibody that is highly specific for the BZs. The limit of detection using 10 microliters samples of urine was 0.3 microgram ml-1 oxazepam. N-Desmethyldiazepam showed equal cross-reactivity to oxazepam, 11 BZs cross-reacted weakly and flurazepam and chlordiazepoxide did not cross-react at levels reported to be found in urine. No cross-reactivity was observed with drugs of abuse and a range of therapeutic drugs commonly found in urine. The assay was used as a screen to detect the presence of BZs in urine from 88 addicts that had been screened by the EMIT technique and a radioreceptor assay (RRA) for BZs. The ELISA produced two false negatives that were EMIT and RRA positive whereas the EMIT produced four different false negatives that were positive by both ELISA and RRA. Thirty-three positives were common to all three assays. The ELISA was also used to monitor nitrazepam-like activity in the urine of a greyhound receiving 5 mg oral medication and the results were compared with those obtained by RRA. Both assays were able to detect nitrazepam-like activity for up to 10 h post-administration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757927     DOI: 10.1039/an9962100951

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  2 in total

1.  Immunoassay Methods and their Applications in Pharmaceutical Analysis: Basic Methodology and Recent Advances.

Authors:  Ibrahim A Darwish
Journal:  Int J Biomed Sci       Date:  2006-09

2.  Parts per trillion detection of 7-aminonitrazepam by nano-enhanced ELISA.

Authors:  Chifang Peng; Xiaohui Duan; Shanshan Song; Feng Xue
Journal:  Int J Mol Sci       Date:  2013-09-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.